Annual report pursuant to Section 13 and 15(d)

Accrued Expenses and Other Current Liabilities (Tables)

v3.24.1
Accrued Expenses and Other Current Liabilities (Tables)
12 Months Ended
Dec. 31, 2023
Payables and Accruals [Abstract]  
Schedule of Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consist of the following:

 

 

December 31,

 

 

 

2023

 

 

2022

 

 

 

(in thousands)

 

Vaxcyte-related accrual under Vaxcyte Supply Agreement

 

$

6,933

 

 

$

4,830

 

CMO-related accrual

 

 

8,195

 

 

 

3,900

 

Clinical trials-related accrual

 

 

4,283

 

 

 

2,954

 

Tax and related expenses

 

 

15,165

 

 

 

-

 

Other

 

 

3,897

 

 

 

3,080

 

Total accrued expenses and other current liabilities

 

$

38,473

 

 

$

14,764